Niklas Marklund

Prof. Niklas Marklund

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Journal of Neurotrauma
Verified
Journal Article
Closed access
HTHilaire J. Thompson
Hilaire J. Thompson
JLJonathan Lifshitz
Jonathan Lifshitz
NMNiklas Marklund
Niklas Marklund
MGM. Sean Grady
M. Sean Grady
DGDavid I. Graham
David I. Graham
TMTracy K. McIntosh
Tracy K. McIntosh
This article comprehensively reviews the lateral fluid percussion (LFP) model of traumatic brain injury (TBI) in small animal species with particular emphasis on its validity, clinical relevance and reliability. The LFP model, initially described in 1989, has become the most extensively utilized animal model of TBI (to date, 232 PubMed citations), producing both focal and diffuse (mixed) brain injury. Despite subtle variations in injury parameters between laboratories, universal findings are evident across studies, including histological, physiological, metabolic, and behavioral changes that serve to increase the reliability of the model. Moreover, demonstrable histological damage and severity-dependent behavioral deficits, which partially recover over time, validate LFP as a clinically-relevant model of human TBI. The LFP model, also has been used extensively to evaluate potential therapeutic interventions, including resuscitation, pharmacologic therapies, transplantation, and other neuroprotective and neuroregenerative strategies. Although a number of positive studies have identified promising therapies for moderate TBI, the predictive validity of the model may be compromised when findings are translated to severely injured patients. Recently, the clinical relevance of LFP has been enhanced by combining the injury with secondary insults, as well as broadening studies to incorporate issues of gender and age to better approximate the range of human TBI within study design. We conclude that the LFP brain injury model is an appropriate tool to study the cellular and mechanistic aspects of human TBI that cannot be addressed in the clinical setting, as well as for the development and characterization of novel therapeutic interventions. Continued translation of pre-clinical findings to human TBI will enhance the predictive validity of the LFP model, and allow novel neuroprotective and neuroregenerative treatment strategies developed in the laboratory to reach the appropriate TBI patients.

1 August 2017 in The Lancet Neurology
Verified
Journal Article
Closed access
MMMarc Maegele
Marc Maegele
HSHerbert Schöchl
Herbert Schöchl
TMTomas Menovsky
Tomas Menovsky
HMHugues Maréchal
Hugues Maréchal
NMNiklas Marklund
Niklas Marklund
SSSimon Stanworth
Simon Stanworth

21 July 2015 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
PHPeter John Ashton Hutchinson
Peter John Ashton Hutchinson
IJIbrahim Jalloh
Ibrahim Jalloh
AHAdel Helmy
Adel Helmy
KCKeri L. H. Carpenter
Keri L. H. Carpenter
ERElham Rostami
Elham Rostami
UUUrban Ungerstedt
Urban Ungerstedt
Microdialysis enables the chemistry of the extracellular interstitial space to be monitored. Use of this technique in patients with acute brain injury has increased our understanding of the pathophysiology of several acute neurological disorders. In 2004, a consensus document on the clinical application of cerebral microdialysis was published. Since then, there have been significant advances in the clinical use of microdialysis in neurocritical care. The objective of this review is to report on the International Microdialysis Forum held in Cambridge, UK, in April 2014 and to produce a revised and updated consensus statement about its clinical use including technique, data interpretation, relationship with outcome, role in guiding therapy in neurocritical care and research applications.

1 January 2005 in Neuroscience
Verified
Journal Article
Closed access
DMD.M. Morales
D.M. Morales
NMNiklas Marklund
Niklas Marklund
DLD. Lebold
D. Lebold
HTH.J. Thompson
H.J. Thompson
APA. Pitkanen
A. Pitkanen
TMT.K. McIntosh
T.K. McIntosh

1 October 2011 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
NMNiklas Marklund
Niklas Marklund
LHLars Hillered
Lars Hillered

3 August 2009 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
FCFredrik Clausen
Fredrik Clausen
AHAnders Hånell
Anders Hånell
MBMaria Björk
Maria Björk
LHLars Hillered
Lars Hillered
AMAnis K. Mir
Anis K. Mir
NMNiklas Marklund
Niklas Marklund